文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

创伤性脑损伤患者的抗凝药物预防:一项系统综述

Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: A systematic review.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论对重复头颅CT稳定的TBI患者,24至72小时启动VTE药物预防与VTE发生率降低相关,且未增加颅内出血。

本系统综述检索五个数据库,纳入17项研究(1项随机对照试验、2项前瞻性观察研究、10项回顾性综述、5项系统综述),评估创伤性脑损伤患者静脉血栓栓塞症药物预防方案的安全性与有效性,采用GRADE标准评价证据质量。多数研究显示,早期药物预防与TBI患者VTE发生率降低相关,且不增加颅内出血。作者结论认为,对于重复头颅CT稳定的颅内出血TBI患者,有理由给予VTE药物预防;24至72小时早期预防与VTE发生率降低相关,且未相应增加或加重颅内出血。作者指出,仍需更多研究以建立成人TBI患者VTE预防方案的安全性与有效性指南。

要点

  • 对重复头颅CT稳定的颅内出血TBI患者,作者认为有理由给予VTE药物预防,证据来自17项研究的系统综述(证据等级III)。
  • 早期(24至72小时)药物预防与TBI患者VTE发生率降低相关,且未增加或加重颅内出血。
  • 启动药物预防的前提是重复头颅CT显示稳定,作者结论明确限定于此类患者。
  • 纳入研究以回顾性综述为主(10项),仅1项随机对照试验,作者指出仍需更多研究以建立指南。

适用人群与场景

  • 创伤性脑损伤(TBI)患者,包括导致颅内出血的TBI患者。
  • 作者结论限定于重复头颅CT扫描稳定的TBI患者。

处置流程与药物剂量

  • 对重复头颅CT稳定的颅内出血TBI患者,作者认为有理由给予VTE药物预防。
  • 早期药物预防的时间窗为24至72小时,与VTE发生率降低相关,且未相应增加或加重颅内出血。

研究设计与关键结果

  • 系统综述纳入17项研究:1项随机对照试验、2项前瞻性观察研究、10项回顾性综述、5项系统综述。
  • 多数研究显示,早期药物预防与TBI患者VTE发生率降低相关,且不增加颅内出血。
  • 作者结论:对重复头颅CT稳定的颅内出血TBI患者,24至72小时早期药物预防与VTE发生率降低相关,且未相应增加或加重颅内出血。

证据类型、等级与局限

  • 证据类型:系统综述,证据等级III。
  • 采用GRADE工作组标准评价证据质量。
  • 局限:作者指出仍需更多研究以建立成人TBI患者VTE预防方案的安全性与有效性指南。

对床旁实践的改变

  • 作者认为,对重复头颅CT稳定的颅内出血TBI患者,有理由给予VTE药物预防。
  • 作者认为,24至72小时早期药物预防与VTE发生率降低相关,且未增加或加重颅内出血。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) continues to be a deadly injury. Universally accepted guidelines regarding the use of venous thromboembolism (VTE) chemoprophylaxis in trauma patients presenting with TBI have not been established. The purpose of this review was to identify and review the current literature and present the evidence for anticoagulant chemoprophylaxis regimens in patients with TBI.

METHODS: A search of five databases including PubMed, Web of Science, Google Scholar, JAMA Network, and Cochrane Journals was conducted for studies evaluating the safety and efficacy of venous thromboembolism prophylaxis regimens according to the Preferred Reporting Items for Systematic reviews and Meta-analyses guidelines. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group criteria were used for quality of evidence assessment.

RESULTS: Seventeen studies were included in this review: 1 randomized controlled trial, 2 prospective observational studies, 10 retrospective reviews, and 5 systematic reviews. Most studies demonstrated that early chemoprophylactic administration is associated with a decreased incidence of VTE in patients with TBI without an increase in intracranial bleed.

CONCLUSION: For patients with TBI resulting in intracranial hemorrhages, administration of VTE chemoprophylaxis is warranted for those patients with stable repeat computed tomography scans. Early chemoprophylaxis, at 24 to 72 hours is associated with reduced VTE incidence without a corresponding increase or exacerbation of intracranial hemorrhage in patients with TBI who have a stable repeat head computed tomography scan. More studies are needed to establish guidelines for the safety and efficacy of VTE prophylaxis protocols in adult patients with TBI.

LEVEL OF EVIDENCE: Systematic review, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Spano PJ, Shaikh S, Boneva D, et al. Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: A systematic review. J Trauma Acute Care Surg. 2020. PMID: 31923051. doi:10.1097/TA.0000000000002580

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。